Cambridge Investment Research Advisors’s Constellium CSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.12M Buy
35,053
+14,764
+73% +$477K ﹤0.01% 2208
2026
Q1
$499K Buy
20,289
+1,469
+8% +$35K ﹤0.01% 2808
2025
Q4
$355K Buy
+18,820
New +$312K ﹤0.01% 3027

Other funds holding CSTM

Cambridge Investment Research Advisors's CSTM Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Constellium (CSTM) stake by 73% in Q2 2026, buying an estimated $477K and bringing the position to 35,053 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #2208.

Cambridge Investment Research Advisors first reported a position in CSTM in Q4 2025 and has held it in 3 quarters since. 388 funds tracked by Wall St. Rank hold CSTM as of Q2 2026.

  • Cambridge Investment Research Advisors held 35,053 shares of Constellium worth $1.12M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 14,764 Constellium shares in Q2 2026, an estimated $477K.
  • Constellium made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2208 holding.
  • Cambridge Investment Research Advisors first reported a position in Constellium in Q4 2025 and has held it in 3 quarters since.
  • 388 funds tracked by Wall St. Rank held Constellium as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.